ID27742A - PHARMACEUTICAL USE OF NAB1 AND NAB2 - Google Patents

PHARMACEUTICAL USE OF NAB1 AND NAB2

Info

Publication number
ID27742A
ID27742A IDW20010345A ID20010345A ID27742A ID 27742 A ID27742 A ID 27742A ID W20010345 A IDW20010345 A ID W20010345A ID 20010345 A ID20010345 A ID 20010345A ID 27742 A ID27742 A ID 27742A
Authority
ID
Indonesia
Prior art keywords
nab1
nab2
pharmaceutical use
pharmaceutical
Prior art date
Application number
IDW20010345A
Other languages
Indonesian (id)
Inventor
Martin Braddock
Callum Jeffrey Cambell
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9814989.1A external-priority patent/GB9814989D0/en
Priority claimed from GBGB9819826.0A external-priority patent/GB9819826D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ID27742A publication Critical patent/ID27742A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IDW20010345A 1998-07-11 1999-07-09 PHARMACEUTICAL USE OF NAB1 AND NAB2 ID27742A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9814989.1A GB9814989D0 (en) 1998-07-11 1998-07-11 Gene therapy method
GBGB9819826.0A GB9819826D0 (en) 1998-09-12 1998-09-12 Gene therapy method

Publications (1)

Publication Number Publication Date
ID27742A true ID27742A (en) 2001-04-26

Family

ID=26314007

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010345A ID27742A (en) 1998-07-11 1999-07-09 PHARMACEUTICAL USE OF NAB1 AND NAB2

Country Status (22)

Country Link
EP (1) EP1097200A1 (en)
JP (1) JP2002520020A (en)
KR (1) KR20010071832A (en)
CN (1) CN1317045A (en)
AP (1) AP2001002038A0 (en)
AU (1) AU763713B2 (en)
BR (1) BR9912018A (en)
CA (1) CA2336805A1 (en)
EA (1) EA200100028A1 (en)
EE (1) EE200100020A (en)
HR (1) HRP20010025A2 (en)
HU (1) HUP0102835A3 (en)
ID (1) ID27742A (en)
IL (1) IL140533A0 (en)
IS (1) IS5788A (en)
NO (1) NO20010166L (en)
NZ (1) NZ509174A (en)
PL (1) PL345507A1 (en)
SK (1) SK382001A3 (en)
TR (1) TR200100622T2 (en)
WO (1) WO2000003014A1 (en)
YU (1) YU1901A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928430D0 (en) * 1999-12-01 2000-01-26 Glaxo Group Ltd Screening
AU2001291019A1 (en) 2000-09-15 2002-03-26 Genvec, Inc. Method of modulating neovascularization
WO2004083435A1 (en) * 2003-03-17 2004-09-30 Julius-Maximilians-Uni Versität Würzburg Nab proteins and their use in diagnostic and therapeutic applications in heart disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5036006A (en) * 1984-11-13 1991-07-30 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US5697901A (en) * 1989-12-14 1997-12-16 Elof Eriksson Gene delivery by microneedle injection

Also Published As

Publication number Publication date
NO20010166D0 (en) 2001-01-10
TR200100622T2 (en) 2001-10-22
AU763713B2 (en) 2003-07-31
EP1097200A1 (en) 2001-05-09
AU4791499A (en) 2000-02-01
NZ509174A (en) 2003-08-29
EE200100020A (en) 2002-06-17
YU1901A (en) 2005-06-10
BR9912018A (en) 2006-01-31
KR20010071832A (en) 2001-07-31
EA200100028A1 (en) 2001-08-27
CN1317045A (en) 2001-10-10
SK382001A3 (en) 2001-09-11
HUP0102835A3 (en) 2003-09-29
CA2336805A1 (en) 2000-01-20
NO20010166L (en) 2001-03-06
JP2002520020A (en) 2002-07-09
HRP20010025A2 (en) 2001-12-31
HUP0102835A2 (en) 2001-11-28
IS5788A (en) 2000-12-22
AP2001002038A0 (en) 2001-03-31
PL345507A1 (en) 2001-12-17
WO2000003014A1 (en) 2000-01-20
IL140533A0 (en) 2002-02-10

Similar Documents

Publication Publication Date Title
ID25504A (en) PREVENTION AND TREATMENT OF AMILOIDOGENIC DISEASE
ID24839A (en) TRIAZOL COMPOUNDS AND ITS USE
ID18320A (en) NEW MEDICINE PRODUCTS AND USES OF IT
ID30393A (en) TIENOPIRIMIDINA COMPOUNDS, MAKING AND USE OF IT
ID27859A (en) TAMPON AND THE METHOD OF MAKING IT
DE69829139D1 (en) MEDICATOR OF ANSANGTYP
ID24476A (en) ARILSULFONAMIDA AND ITS ANALOGUE
ID24524A (en) COMBINATIONS FOR REDUCTION OF ALDOSA REDUCTIVES AND GLICOGEN PHOSPHEREILASE OBSTACLES
ID20321A (en) CRUDE PREVENTION Substances and METHODS OF USE
ID27480A (en) STRUCTURE WRAPPING AND ITS ELEMENT
ID27510A (en) SUBSTITUTIONAL MALIMIDE COMPOUNDS AND PHARMACY USE
ID24828A (en) PHARMACY COMPOSITIONS OF TIZOKSIANIDA AND NITAZOKSANIDA
FI965204A0 (en) Medicinal use of bromelain
DE69900823D1 (en) INJECTABLE MEDICINAL PREPARATION CONSISTING OF PARACETAMOL
FI964619A0 (en) Dosage of antiepileptic drugs on the skin
PT1194038E (en) COMPOSITION OF BREACH OF THE REST AND ITS USE
ID27742A (en) PHARMACEUTICAL USE OF NAB1 AND NAB2
ID26979A (en) MATERIALS AND ITS USE
ID24065A (en) TREATMENT OF DIABETES WITH TIOZOLIDINDINONE AND SULFONILUREA
FI963263A0 (en) Medical use of bromelain
DE29817550U1 (en) Dosing device and application of the same
ID19848A (en) COMPOUND 1-ARILPIRAZOL PRODUCTS AND ITS USE
ID23048A (en) PHARMACEUTICAL COMPOSITION OF HEDGEHOG PROTEIN AND USE A
ID30330A (en) BEZOFURAN DERIVAL, MANUFACTURE AND USE OF IT
ID19017A (en) SPIRO-PIPERIDIN DECREASES AND THE USE OF THERAPEUTIC MATERIALS